Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04066348 · ClinicalTrials.gov registry record · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
A Phase 2 study of Tinnitus, Noise Induced, sponsored by Wayne State University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 88
- Enrollment target
- 4
- Study locations
NCT04066348 is a Phase 2 study of Tinnitus, Noise Induced that is actively recruiting participants, run by Wayne State University. The registered enrollment target is 88 participants. The trial reports 4 study locations across 2 states.
The verdict
NCT04066348, a Phase 2 study of Tinnitus, Noise Induced, is actively recruiting participants, sponsored by Wayne State University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 88 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this multi-site research study is to determine if Etanercept, compared to a placebo, significantly reduces the severity of tinnitus (ringing in the ears) associated with history of blast and/or noise exposure or associated with Traumatic Brain Injury (TBI) and/or concussion. Individuals who qualify will be randomized into one of two groups: The group receiving the medication Etanercept or the group receiving a saline solution placebo.
Conditions Studied
Interventions
- BIOLOGICAL Etanercept
- OTHER Saline
Study Locations (4)
Florida
- Advent Health - Celebration
- University of Miami - Coral Gables
Michigan
- Wayne State University - Detroit
- Michigan Ear Institute - Farmington Hills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2026-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04066348
The ClinicalTrials.gov registry entry for NCT04066348 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tinnitus, Noise Induced appearing as the primary indexed condition, and to 2 interventions - of which Etanercept is the first listed.
NCT04066348 reports 4 study locations spanning 2 distinct geographic areas - top geographies include Florida, Michigan.
Frequently Asked Questions
What is clinical trial NCT04066348 about?
NCT04066348 is a clinical study titled "TNF-α Treatment of Blast-Induced Tinnitus". The purpose of this multi-site research study is to determine if Etanercept, compared to a placebo, significantly reduces the severity of tinnitus (ringing in the ears) associated with history of blast and/or noise exposure or associated with Traumatic Brain Injury (TBI) and/or concussion. Individua...
What is the current status of trial NCT04066348?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 88 participants. The study started on 2022-07-01. Estimated completion is 2026-09.
What conditions does trial NCT04066348 study?
This clinical trial studies the following conditions: Tinnitus, Noise Induced.
What interventions are being tested in trial NCT04066348?
The interventions under investigation include: Etanercept (BIOLOGICAL), Saline (OTHER).
Who is sponsoring clinical trial NCT04066348?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04066348 being conducted?
This trial has 4 study locations across Florida, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tinnitus, Noise Induced
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.